[Case for diagnosis. Telangiectasia macularis eruptiva perstans]. / Caso para diagnóstico. Telangiectasia macularis eruptiva perstans.

We report a case of telangiectasia macularis eruptiva perstans in an 18-year-old male patient who developed multiple erythematous maculae on the trunk and limbs. Darier's sign was positive. Histopathology revealed mononuclear cell infiltrate and increased number of mast cells identified with Giemsa staining. Telangiectasiamacularis eruptiva perstans should be considered in patients with telangiectatic lesions of atypical appearance or distribution which start in childhood.

Caso para diagnóstico / Case for diagnosis

Descreve-se um caso de telangiectasia macularis eruptiva perstans em paciente do sexo masculino de 18 anos com história de máculas telangiectásicas disseminadas por tronco e membros. O sinal de Darier foi positivo. O exame histopatológico mostrou infiltrado inflamatório mononuclear, com acúmulo de mastócitos ao Giemsa. A telangiectasia macularis eruptiva perstans deve ser considerada em pacientes que apresentem lesões telangiectásicas de aparência e distribuição atípicas com início na infância.

We report a case of telangiectasia macularis eruptiva perstans in an 18-year-old male patient who developed multiple erythematous maculae on the trunk and limbs. Darier’s sign was positive. Histopathology revealed mononuclear cell infiltrate and increased number of mast cells identified with Giemsa staining. Telangiectasia macularis eruptiva perstansshould be considered in patients with telangiectatic lesions of atypical appearance or distribution which start in childhood.

Telangiectasia hemorrágica hereditária: ácido tranexâmico no tratamento de úlcera plantar / Hereditary hemorrhagic telangiectasia: tranexamic acid for plantar ulcer

Relato de um caso de úlcera plantar por fístula arteriovenosa em paciente portador de telangiectasia hemorrágica hereditária ou doença de Rendu-Osler-Weber tratado com ácido tranexâmico. Este fármaco é utilizado para tratamento de epistaxe, referindo-se o principal achado deste artigo ao uso eficaz desse medicamento na terapia de úlceras plantares hemorrágicas. São descritos os aspectos fisiopatológicos e clínicos da doença e as propriedades antifibrinolíticas do ácido tranexâmico. Este foi bem tolerado e apresentou evidências de eficácia na utilização para controle do sangramento e cicatrização da úlcera.

Case report of one patient with Hereditary Hemorrhagic Telangiectasia, also known as Rendu-Osler-Weber syndrome, treated with Tranexamic Acid for arteriovenous plantar ulcer. This drug has proved effective in controlling epistaxis, but the main point of this report is to expose the success use of this medication in the therapy of skin bleeding ulcer. The pathophysiologic and clinical features of the disease are reviewed and also the pharmacological aspects of the antifibrinolytic drugs. This drug was well tolerated by the patient and show evidence of good activity in the bleeding and healed the ulcer.